semaglutide normal bmi Long-term weight loss effects of in obesity without diabetes in the SELECT trial Who Qualifies for Semaglutide GLP-1

The medication also slows gastric emptying, which helps moderate postprandial glucose excursions

Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells

Insulin resistance severity plays a significant rolepatients with longstanding type 2 diabetes or very high baseline HbA1c levels may have reduced beta-cell function, which can limit the medication's glucose-lowering capacity

Document progress to review during plateau periods later

Weight Loss as a Foundation for Liver Health Improvement Sustained weight loss remains the gold standard for fatty liver disease management, with even 5-10% body weight reduction improving liver histology and markers of inflammation

Research supports a step-down approach where you reduce calories by 200-300 per week rather than making dramatic cuts